Define range intervals using parentheses.
E.g. C7H(10-14)O(0-4)

to
±
(example: 123 ± 1)

to
±

to
±
 

to
±
 
Search Hits Limit:
Single/Multi-component
Isotopically Labeled
Additional Filters

Found 466 results

Search term: MF = 'C_{31}H_{33}ClN_{4}O'
12345
IDStructureMolecular FormulaMolecular Weight# of Data Sources# of References# of PubMed# of RSC
5012559

Double-bond stereo

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C31H33ClN4O/c1-34(2)26-15-11-21(12-16-26)19-23-7-6-10-28-29(23)33-36(31(37)24-8-5-9-25(32)20-24)30(28)22-13-17-27(18-14-22)35(3)4/h5,8-9,11-20,28,30H,6-7,10H2,1-4H3/b23-19+
C31H33ClN4O513.0729171100
4790267

Double-bond stereo

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C31H33ClN4O/c1-34(2)26-16-8-21(9-17-26)20-24-6-5-7-28-29(24)33-36(31(37)23-10-14-25(32)15-11-23)30(28)22-12-18-27(19-13-22)35(3)4/h8-20,28,30H,5-7H2,1-4H3/b24-20+
C31H33ClN4O513.0729141100
5011412

Double-bond stereo

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C31H33ClN4O/c1-34(2)24-16-12-21(13-17-24)20-23-8-7-10-27-29(23)33-36(31(37)26-9-5-6-11-28(26)32)30(27)22-14-18-25(19-15-22)35(3)4/h5-6,9,11-20,27,30H,7-8,10H2,1-4H3/b23-20+
C31H33ClN4O513.072912900
4237700
InChI=1/C31H33ClN4O/c1-22-11-12-24(19-23(22)2)30-21-28(27-9-3-4-10-29(27)34-30)31(37)33-13-6-14-35-15-17-36(18-16-35)26-8-5-7-25(32)20-26/h3-5,7-12,19-21H,6,13-18H2,1-2H3,(H,33,37)
C31H33ClN4O513.0729210800
10907839

Double-bond stereo
InChI=1/C31H32N4O.ClH/c1-24-12-14-26(15-13-24)31-27(23-35(33-31)29-10-6-3-7-11-29)16-17-30(36)32-28-18-20-34(21-19-28)22-25-8-4-2-5-9-25;/h2-17,23,28H,18-22H2,1H3,(H,32,36);1H/b17-16+;
C31H33ClN4O513.07298400
3287257

Double-bond stereo

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C31H33ClN4O/c1-34(2)26-15-11-21(12-16-26)19-23-7-6-10-28-29(23)33-36(31(37)24-8-5-9-25(32)20-24)30(28)22-13-17-27(18-14-22)35(3)4/h5,8-9,11-20,28,30H,6-7,10H2,1-4H3
C31H33ClN4O513.07297600
30640526

Double-bond stereo
InChI=1/C31H32N4O.ClH/c1-24-12-14-26(15-13-24)31-27(23-35(33-31)29-10-6-3-7-11-29)16-17-30(36)32-28-18-20-34(21-19-28)22-25-8-4-2-5-9-25;/h2-17,23,28H,18-22H2,1H3,(H,32,36);1H
C31H33ClN4O513.07296700
3457157

Double-bond stereo

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C31H33ClN4O/c1-34(2)26-16-8-21(9-17-26)20-24-6-5-7-28-29(24)33-36(31(37)23-10-14-25(32)15-11-23)30(28)22-12-18-27(19-13-22)35(3)4/h8-20,28,30H,5-7H2,1-4H3
C31H33ClN4O513.072925400
3102364

Double-bond stereo

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C31H33ClN4O/c1-34(2)24-16-12-21(13-17-24)20-23-8-7-10-27-29(23)33-36(31(37)26-9-5-6-11-28(26)32)30(27)22-14-18-25(19-15-22)35(3)4/h5-6,9,11-20,27,30H,7-8,10H2,1-4H3
C31H33ClN4O513.07295500
29260152
InChI=1/C31H33ClN4O/c1-22-10-12-23(13-11-22)30-28(21-34-16-18-35(19-17-34)31(37)24-6-2-3-7-24)36-20-25(14-15-29(36)33-30)26-8-4-5-9-27(26)32/h4-5,8-15,20,24H,2-3,6-7,16-19,21H2,1H3
C31H33ClN4O513.07295500
20183739

Double-bond stereo

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C31H33ClN4O/c1-34(2)26-15-11-21(12-16-26)19-23-7-6-10-28-29(23)33-36(31(37)24-8-5-9-25(32)20-24)30(28)22-13-17-27(18-14-22)35(3)4/h5,8-9,11-20,28,30H,6-7,10H2,1-4H3/b23-19-
C31H33ClN4O513.07294200
24698549
InChI=1/C31H33ClN4O/c32-21-14-15-24-28(20-21)36-26-11-4-2-9-23(26)31(24)34-18-6-16-33-17-7-19-37-29-13-5-12-27-30(29)22-8-1-3-10-25(22)35-27/h1,3,5,8,10,12-15,20,33,35H,2,4,6-7,9,11,16-19H2,(H,34,36)
C31H33ClN4O513.07293300
84438925
InChI=1/C31H32N4O.ClH/c1-22-10-8-18-34-30(22)32-23(2)25(31(34)36)16-19-33-17-9-15-29-27(21-33)26-13-6-7-14-28(26)35(29)20-24-11-4-3-5-12-24;/h3-8,10-14,18H,9,15-17,19-21H2,1-2H3;1H
C31H33ClN4O513.07293200
90619082
InChI=1/C31H32N4O.ClH/c1-4-34-29-20-23(12-13-25(29)27-15-17-32-21(2)30(27)34)36-19-9-5-8-18-35-28-11-7-6-10-24(28)26-14-16-33-22(3)31(26)35;/h6-7,10-17,20H,4-5,8-9,18-19H2,1-3H3;1H
C31H33ClN4O513.07292200
90620597
InChI=1/C31H32N4O.ClH/c1-3-4-17-35-29-20-23(11-12-25(29)27-14-16-33-22(2)31(27)35)36-19-8-7-18-34-28-10-6-5-9-24(28)26-13-15-32-21-30(26)34;/h5-6,9-16,20-21H,3-4,7-8,17-19H2,1-2H3;1H
C31H33ClN4O513.07292200
90623550
InChI=1/C31H32N4O.ClH/c1-3-34-29-20-23(12-13-25(29)27-15-17-33-22(2)31(27)34)36-19-9-5-4-8-18-35-28-11-7-6-10-24(28)26-14-16-32-21-30(26)35;/h6-7,10-17,20-21H,3-5,8-9,18-19H2,1-2H3;1H
C31H33ClN4O513.07292200
7817449

Double-bond stereo

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C31H33ClN4O/c1-34(2)26-15-11-21(12-16-26)19-23-7-6-10-28-29(23)33-36(31(37)24-8-5-9-25(32)20-24)30(28)22-13-17-27(18-14-22)35(3)4/h5,8-9,11-20,28,30H,6-7,10H2,1-4H3/b23-19+/t28-,30+/m1/s1
C31H33ClN4O513.07292100
7817450

Double-bond stereo

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C31H33ClN4O/c1-34(2)26-15-11-21(12-16-26)19-23-7-6-10-28-29(23)33-36(31(37)24-8-5-9-25(32)20-24)30(28)22-13-17-27(18-14-22)35(3)4/h5,8-9,11-20,28,30H,6-7,10H2,1-4H3/b23-19+/t28-,30-/m0/s1
C31H33ClN4O513.07292100
9331637

2 of 3 defined stereocentres - 2/3 defined
InChI=1/C31H33ClN4O/c1-21(28(18-22-9-15-27(32)16-10-22)26-8-6-7-23(17-26)19-33)35-29(31(2,3)20-34)24-11-13-25(14-12-24)30(37)36(4)5/h6-17,21,28-29,35H,18H2,1-5H3/t21-,28+,29?/m0/s1
C31H33ClN4O513.07292100
10121220

Double-bond stereo

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C31H33ClN4O/c1-34(2)26-16-8-21(9-17-26)20-24-6-5-7-28-29(24)33-36(31(37)23-10-14-25(32)15-11-23)30(28)22-12-18-27(19-13-22)35(3)4/h8-20,28,30H,5-7H2,1-4H3/b24-20+/t28-,30+/m1/s1
C31H33ClN4O513.07292100
12345

Advertisement